Zofran Side Effect: Irregular Heartbeat 

Posted on March 18, 2016

Ondansetron, which is marketed under the brand name Zofran, was approved by the U.S. Food and Drug Administration (FDA) in 1998. Zofran was developed by British pharmaceutical giant GlaxoSmithKline (GSK). It was marketed as a remedy for nausea—particularly in women suffering from morning sickness during pregnancy. However, the FDA did not approve it for that purpose.

Zofran has been widely used in recent years, but has now been linked to side effects like serotonin syndrome, which occurs when there is too much of that neurotransmitter in the body. Many women who used the drug during pregnancy now claim it caused birth defects in their children. The jury is still out on how much of a risk Zofran is during pregnancy.

Zofran Use Conntected to QT Syndrome

One of the most serious and potentially fatal side effects linked to Zofran use is called QT syndrome. The period of time between when your heart expands and contracts is known as the “QT interval.” Zofran can disrupt the electrical impulses to the heart, causing the QT interval to expand (QT syndrome). QT syndrome can be dangerous because it can lead to an episode of Torsade de pointes, which is when the heart rhythm becomes irregular and doesn’t pump enough blood to the brain. Torsade de pointes can cause fainting, permanent brain damage, and even death.

Contact a Pharmaceutical Litigation Attorney Today

If you have suffered side effects from taking Zofran, or lost a loved one who was taking Zofran, you need to contact a pharmaceutical litigation attorney. The skilled legal team at Farah & Farah has represented injury victims and their families since 1979. We are now handling Zofran-related injury claims nationwide.

To pursue a settlement that is worthy of you and your family’s losses, call Farah & Farah at (800) 533-3555 for a free consultation today.

  • This field is for validation purposes and should be left unchanged.